Development of neurocognitive disorders in HIV/AIDS

References

• Centers for Disease Control and Prevention. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30(25): 305–308.
   PubMedGoogle Scholar
• Ances BM, Letendre SL, Alexander T, Ellis RJ. Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders. Int Rev Psychiatry. 2008;20(1):89–93.
   PubMed Web of Science ®Google Scholar
• AIDS Epidemic Update 2009. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO); 2009.
   Google Scholar
• Quinn TC, Glasser D, Cannon RO, et al. Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med. 1988;318(4):197–203.
   Web of Science ®Google Scholar
• Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1988; 319(24):1573–1578.
   PubMed Web of Science ®Google Scholar
• Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group. AIDS. 1992;6(7):671–677.
   Web of Science ®Google Scholar
• Food and Drug Administration, US Department of Health and Human Services. HIV/AIDS historical timeline 1981–1990. Available from: http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm151074.htm. Accessed October 25, 2010.
   Google Scholar
• Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997;11(14):1731–1738.
   PubMed Web of Science ®Google Scholar
• Powderly WG. Sorting through confusing messages: the art of HAART. J Acquir Immune Defic Syndr. 2002;31 Suppl 1:S3–S9; discussion S24–S25.
   PubMedGoogle Scholar
• Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ; National HIV Surveillance Committee. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 2003;17(10):1539–1545.
   Google Scholar
• Gonzalez R, Cherner M. Co-factors in HIV neurobehavioural disturbances: substance abuse, hepatitis C and aging. Int Rev Psychiatry. 2008;20(1):49–60.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Clifford DB, Franklin DR Jr, et al; CHARTER Group. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23): 2087–2096.
   PubMed Web of Science ®Google Scholar
• Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–1250.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Grant I, Butters N, et al. The HNRC 500 – neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1(3):231–251.
   PubMedGoogle Scholar
• Grant I. Neurocognitive disturbances in HIV. Int Rev Psychiatry. 2008;20(1):33–47.
   PubMed Web of Science ®Google Scholar
• Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19(6):517–524.
   PubMed Web of Science ®Google Scholar
• Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41(6):778–785.
   Google Scholar
• Bottiggi KA, Chang JJ, Schmitt FA, et al. The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci. 2007;260(1–2):11–15.
   PubMed Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18): 1789–1799.
   PubMed Web of Science ®Google Scholar
• Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J. Evolution of HIV dementia with HIV infection. Int Rev Psychiatry. 2008;20(1):25–31.
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136–142.
   PubMed Web of Science ®Google Scholar
• Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV dementia and related cognitive disorders. Neurology. 1996;47(5):1247–1253.
   PubMedGoogle Scholar
• Marder K, Albert SM, McDermott MP, et al. Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology. 2003;60(9):1467–1473.
   Web of Science ®Google Scholar
• Vivithanaporn P, Heo G, Gamble J, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 2010;75(13):1150–1158.
   PubMed Web of Science ®Google Scholar
• McArthur JC, Sacktor N, Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol. 1999;19(2):129–150.
   PubMed Web of Science ®Google Scholar
• McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157(1–2):3–10.
   Web of Science ®Google Scholar
• Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987;44(1): 65–69.
   PubMedGoogle Scholar
• Gray F, Geny C, Lionnet F, et al. Neuropathologic study of 135 adult cases of acquired immunodeficiency syndrome (AIDS). Ann Pathol. 1991;11(4):236–247.
   Web of Science ®Google Scholar
• Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology. 1998;50(6):1814–1820.
   Web of Science ®Google Scholar
• Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
   Google Scholar
• McArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study. Ann Neurol. 1989;26(5):601–611.
   PubMed Web of Science ®Google Scholar
• McArthur JC, Selnes O. Human immunodeficiency virus-associated dementia. In: Berger JR, Levy RM, editors. AIDS and the Nervous System. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1997: 527–567.
   Google Scholar
• Butters N, Grant I, Haxby J, et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol. 1990;12(6): 963–978.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Miller SW, Taylor MJ, Grant I. Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults. Lutz, FL: Psychological Assessment Resources; 2004.
   Google Scholar
• Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993.
   Google Scholar
• Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(3):273–278.
   PubMedGoogle Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
   PubMed Web of Science ®Google Scholar
• Lojek E, Bornstein RA. The stability of neurocognitive patterns in HIV infected men: classification considerations. J Clin Exp Neuropsychol. 2005;27(6):665–682.
   PubMed Web of Science ®Google Scholar
• Dawes S, Suarez P, Casey CY, et al; HNRC Group. Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol. 2008;30(6):613–626.
   PubMed Web of Science ®Google Scholar
• Delis DC, Peavy G, Heaton RK, et al; HNRC Group. Do patients with HIV-associated minor cognitive/motor disorder exhibit a “subcortical” memory profile? Evidence using the California verbal learning test. Assessment. 1995;2(2):151–165.
   Google Scholar
• Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I; HIV Neurobehavioral Research Center (HNRC) Group. Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol. 2006;28(4):536–548.
   PubMed Web of Science ®Google Scholar
• Martin EM, Nixon H, Pitrak DL, et al. Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp Neuropsychol. 2007;29(5): 496–504.
   PubMed Web of Science ®Google Scholar
• Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152–168.
   PubMed Web of Science ®Google Scholar
• Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc. 2002;8(3):410–424.
   PubMed Web of Science ®Google Scholar
• Bartok JA, Martin EM, Pitrak DL, et al. Working memory deficits in HIV-seropositive drug users. J Int Neuropsychol Soc. 1997;3(5):451–456.
   PubMed Web of Science ®Google Scholar
• Martin EM, Sullivan TS, Reed RA, et al. Auditory working memory in HIV-1 infection. J Int Neuropsychol Soc. 2001;7(1):20–26.
   PubMed Web of Science ®Google Scholar
• Perdices M, Cooper DA. Simple and choice reaction time in patients with human immunodeficiency virus infection. Ann Neurol. 1989; 25(5):460–467.
   Web of Science ®Google Scholar
• Tozzi V, Balestra P, Galgani S, et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS. 1999;13(14):1889–1897.
   PubMed Web of Science ®Google Scholar
• Grant I, Atkinson JH, Hesselink JR, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987;107(6):828–836.
   PubMed Web of Science ®Google Scholar
• Wolters PL, Brouwers P, Civitello L, Moss HA. Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study. AIDS. 1997;11(9):1135–1144.
   Web of Science ®Google Scholar
• Levin BE, Berger JR, Didona T, Duncan R. Cognitive function in asymptomatic HIV-1 infection: the effects of age, education, ethnicity, and depression. Neuropsychology. 1992;6(4):303–313.
   Google Scholar
• Stern RA, Silva SG, Chaisson N, Evans DL. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol. 1996;53(2): 148–153.
   PubMedGoogle Scholar
• Blanchette N, Smith ML, King S, Fernandes-Penney A, Read S. Cognitive development in school-age children with vertically transmitted HIV infection. Dev Neuropsychol. 2002;21(3):223–241.
   PubMed Web of Science ®Google Scholar
• Green JE, Saveanu RV, Bornstein RA. The effect of previous alcohol abuse on cognitive function in HIV infection. Am J Psychiatry. 2004;161(2):249–254.
   PubMed Web of Science ®Google Scholar
• Iudicello JE, Woods SP, Parsons TD, Moran LM, Carey CL, Grant I. Verbal fluency in HIV infection: a meta-analytic review. J Int Neuropsychol Soc. 2007;13(1):183–189.
   PubMed Web of Science ®Google Scholar
• Woods SP, Morgan EE, Dawson M, Cobb Scott J, Grant I; HIV Neurobehavioral Research Center (HNRC) Group. Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1. J Clin Exp Neuropsychol. 2006;28(6): 1030–1042.
   PubMed Web of Science ®Google Scholar
• Cysique LA, Maruff P, Brew BJ. The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis. J Int Neuropsychol Soc. 2006;12(3):368–382.
   PubMed Web of Science ®Google Scholar
• Hardy DJ, Hinkin CH. Reaction time performance in adults with HIV/AIDS. J Clin Exp Neuropsychol. 2002;24(7):912–929.
   PubMed Web of Science ®Google Scholar
• Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol. 2000;6(1):84–88.
   Web of Science ®Google Scholar
• Foley J, Ettenhofer M, Wright M, Hinkin CH. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep. 2008;5(4): 204–211.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. HIV prevalence estimates – United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(39): 1073–1076.
   PubMedGoogle Scholar
• Van Gorp WG, Miller EN, Marcotte TD, et al. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology. 1994;44(5):929–935.
   PubMed Web of Science ®Google Scholar
• Cherner M, Ellis RJ, Lazzaretto D, et al; HIV Neurobehavioral Research Center Group. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS. 2004;18 Suppl 1:S27–S34.
   PubMed Web of Science ®Google Scholar
• Valcour VG, Shikuma CM, Watters MR, Sacktor NC. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS. 2004;18 Suppl 1:S79–S86.
   PubMed Web of Science ®Google Scholar
• Van Gorp WG, Mitrushina M, Cummings JL, Satz P, Modesitt J. Normal aging and the subcortical encephalopathy of AIDS: a neuropsychological comparison. Neuropsychiatry Neuropsychol Behav Neurol. 1989;2(1):5–20.
   Google Scholar
• Foley J, Ettenhofer M, Wright MJ, et al. Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol. 2010;24(2):265–285.
   PubMed Web of Science ®Google Scholar
• Wright EJ, Grund B, Robertson K, et al; INSIGHT SMART Study Group. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010; 75(10):864–873.
   PubMed Web of Science ®Google Scholar
• Bergersen BM. Cardiovascular risk in patients with HIV infection: impact of antiretroviral therapy. Drugs. 2006;66(15):1971–1987.
   PubMed Web of Science ®Google Scholar
• Friis-Møller N, Sabin CA, Weber R, et al; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.
   PubMed Web of Science ®Google Scholar
• Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831–837.
   PubMed Web of Science ®Google Scholar
• Van Gorp WG, Lamb DG, Schmitt FA. Methodologic issues in neuropsychological research with HIV-spectrum disease. Arch Clin Neuropsychol. 1993;8(1):17–33.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Coinfection with HIV and hepatitis C virus. 2005. Available from: http://www.cdc.gov/hiv/resources/factsheets/PDF/coinfection.pdf. Accessed September 27, 2010.
   Google Scholar
• Paul R, Letendre S, Dearborn J. Impact of hepatitis C coinfection on cognitive outcomes in HIV-infected individuals. Curr Hepatitis Rep. 2007;6(4):145–152.
   Google Scholar
• Perry W, Carlson MD, Barakat F, et al. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS. 2005;19 Suppl 3:S79–S84.
   PubMed Web of Science ®Google Scholar
• Nath A, Hauser KF, Wojna V, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr. 2002; 31 Suppl 2:S62–S69.
   PubMed Web of Science ®Google Scholar
• Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR. Acceleration of HIV dementia with methamphetamine and cocaine. J Neurovirol. 2001;7(1):66–71.
   PubMed Web of Science ®Google Scholar
• Nath A, Anderson C, Jones M, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000;14(3):222–227.
   PubMed Web of Science ®Google Scholar
• Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain. 1998;121(Pt 11): 2043–2052.
   PubMedGoogle Scholar
• Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 1991;82(1):39–44.
   Web of Science ®Google Scholar
• Atkinson JH Jr, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry. 1988;45(9):859–864.
   PubMed Web of Science ®Google Scholar
• Dubé B, Benton T, Cruess DG, Evans DL. Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci. 2005; 30(4):237–246.
   PubMed Web of Science ®Google Scholar
• Ickovics JR, Hamburger ME, Vlahov D, et al; HIV Epidemiology Research Study Group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11): 1466–1474.
   PubMed Web of Science ®Google Scholar
• Gibbie T, Mijch A, Ellen S, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med. 2006;7(2):112–121.
   PubMed Web of Science ®Google Scholar
• Farinpour R, Miller EN, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol. 2003;25(5):654–670.
   PubMed Web of Science ®Google Scholar
• Adler NE, Boyce T, Chesney MA, et al. Socioeconomic status and health. The challenge of the gradient. Am Psychol. 1994;49(1):15–24.
   PubMed Web of Science ®Google Scholar
• Smedley BD, Stith AY, Nelson AR, editors. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington (DC): The National Academies Press; 2003.
   Google Scholar
• Fox JW. Mothers’ influence on their adolescents’ tendency to seek medical care. J Adolesc Health. 1991;12(2):116–123.
   Web of Science ®Google Scholar
• Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448–460.
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10): 2015–2028.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Letendre SL. Biomarkers of HIV related central nervous system disease. Int Rev Psychiatry. 2008;20(1):73–88.
   PubMed Web of Science ®Google Scholar
• Brew BJ. Markers of AIDS dementia complex: the role of cerebrospinal fluid assays. AIDS. 2001;15(14):1883–1884.
   Web of Science ®Google Scholar
• Avison MJ, Nath A, Berger JR. Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci. 2002;25(9):468–473.
   Web of Science ®Google Scholar
• Aylward EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry. 1995;152(7):987–994.
   Web of Science ®Google Scholar
• Dal Pan GJ, McArthur JH, Aylward E, et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology. 1992;42(11):2125–2130.
   PubMed Web of Science ®Google Scholar
• Stout JC, Ellis RJ, Jernigan TL, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol. 1998;55(2):161–168.
   PubMedGoogle Scholar
• Kieburtz KD, Ketonen L, Zettelmaier AE, Kido D, Caine ED, Simon JH. Magnetic resonance imaging findings in HIV cognitive impairment. Arch Neurol. 1990;47(6):643–645.
   Google Scholar
• Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR. Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol. 2004;157(1–2):140–146.
   Web of Science ®Google Scholar
• Roc AC, Ances BM, Chawla S, et al. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol. 2007;64(9):1249–1257.
   Google Scholar
• Mohamed MA, Lentz MR, Lee V, et al. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia. Radiology. 2010;254(2): 577–586.
   Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Washington, DC: US Department of Health and Human Services; December 1, 2009.
   Google Scholar
• Abbas AK, Lichtman AH. Basic Immunology. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2011.
   Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, et al; CHARTER Group. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65–70.
   PubMed Web of Science ®Google Scholar
• Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd; International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS. 2009;23(14):1893–1901.
   PubMed Web of Science ®Google Scholar
• Letendre SL, McCutchan JA, Childers ME, et al; HNRC Group. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol. 2004;56(3):416–423.
   PubMed Web of Science ®Google Scholar
• Liner J, Meeker RB, Robertson K. CNS toxicity of antiretroviral drugs. 17th Conference on Retroviruses and Opportunistic Infections; 2010 Feb 16–19; San Francisco, CA, USA.
   Google Scholar
• Winston A, Duncombe C, Li PC, et al; Altair Study Group. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis. 2010;50(6):920–929.
   PubMed Web of Science ®Google Scholar
• Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007;27(1):86–92.
   PubMed Web of Science ®Google Scholar
• Schifitto G, Navia BA, Yiannoutsos CT, et al; Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; HIV MRS Consortium. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS. 2007;21(14):1877–1886.
   PubMed Web of Science ®Google Scholar